Sophie Bakalar is a venture capitalist. She is currently a Partner at Lux Capital, a venture capital firm that invests in scientific and technological companies. Before joining Lux Capital, Bakalar worked as an analyst at Bessemer Venture Partners and a consultant at McKinsey & Company.
She has workedBeforeBeforewithin the venture capital industry for several years and has experience in various sectors, including healthcare, energy, and technology. She is also a member of the board of several companies, including Guardant Health, Osmo, and Celularity.
As a venture capitalist, her role is to help identify, evaluate, and invest in early-stage companies with the potential for significant growth. She also works closely with the companies she has invested in to help them develop and grow their businesses.